Zobrazeno 1 - 7
of 7
pro vyhledávání: '"David Synhorst"'
Publikováno v:
Journal of Neuroinflammation, Vol 16, Iss 1, Pp 1-8 (2019)
Abstract Background Cerebrospinal fluid (CSF) shunt placement is frequently complicated by bacterial infection. Shunt infection diagnosis relies on bacterial culture of CSF which can often produce false-negative results. Negative cultures present a c
Externí odkaz:
https://doaj.org/article/f1b7ea6ce56c49ef810fda60a93e1fc8
Publikováno v:
Critical Care Medicine. 47:583
Autor:
Michiel Coppens, Olga Shestakovska, John W. Eikelboom, Salim Yusuf, Stuart J. Connolly, David Synhorst
Publikováno v:
European heart journal, 35(28), 1856-1863. Oxford University Press
Aim The AVERROES double-blinded, randomized trial demonstrated that apixaban reduces the risk of stroke or systemic embolism (SSE) by 55% compared with aspirin without an increase in major bleeding in patients with atrial fibrillation either who prev
Autor:
Martin S. Bilsker, J. Thomas Heywood, Alan Niederman, David Synhorst, Bruce J Iteld, George A Ponce, Marc Klapholz, Ignatius Thomas, Calvin Eng
Publikováno v:
The American Journal of Cardiology. 88:657-661
Omapatrilat, a novel vasopeptidase inhibitor, is a highly potent and selective inhibitor of neutral endopeptidase and angiotensin-converting enzyme; its therapeutic potential is being investigated for treatment of hypertension and heart failure. In t
Autor:
Janice Pogue, Robert G. Hart, Rafael Diaz, Prem Pais, Greg C. Flaker, Campbell D. Joyner, Salim Yusuf, Stuart J. Connolly, David Synhorst, Stefan H. Hohnloser, Martin O'Donnell, Jack Lawrence, John W. Eikelboom
Publikováno v:
American heart journal. 159(3)
Background Many patients with atrial fibrillation (AF) at moderate or high risk for stroke are not treated with a vitamin K antagonist (VKA). Presently, the only alternative to a VKA with a labeled indication for AF is antiplatelet therapy with acety
Autor:
Susan Chrolavicius, Campbell D. Joyner, Ernesto Paolasso, William S. Weintraub, Nicholas Karatzas, G Frangin, S H Hohnloser, C Proste, Karl Swedberg, J-Y Le Heuzey, Ron J.G. Peters, Fernando Lanas, Heather M. Arthur, W. Van Mieghem, Active W Investigators, Basil S. Lewis, A Budaj, M-G Franzosi, Matyas Keltai, João Morais, Carlos A. Morillo, Gregory C. Flaker, Mel Blumenthal, Patrick J. Commerford, David A. Halon, Mario Talajic, Petr Jansky, Christopher B. Granger, John Varigos, Samuel Z. Goldhaber, M Bethala-Sithya, Marcus Flather, Eva Sitkei, C P Lau, Christophe Gaudin, Rafael Diaz, T Pipillis, L Ceremuzynski, John Camm, Antonio G. Hermosillo, M Pfisterer, A Avezum, Ali Oto, Robert G. Hart, David M. Hunt, Leopoldo S. Piegas, Stuart J. Connolly, David Synhorst, R. De Caterina, Vicent Valentin, Inderjit Anand, Keith A.A. Fox, V Trégou, Marc A. Pfeffer, Sergey P. Golitsyn, Salim Yusuf
Publikováno v:
American heart journal, 151(6), 1187-1193. Mosby Inc.
Background Atrial fibrillation (AF) is the most frequently occurring cardiac arrhythmia with often serious clinical consequences. Many patients have contraindications to anticoagulation, and it is often underused in clinical practice. The addition of
Autor:
Michael E. Matlak, Dale G. Johnson, Yeai Roan, James P. Byrne, Edwin C. McGough, David Synhorst
Publikováno v:
The American journal of cardiology. 43(3)
A case of conjoined thoracopagous twins with a shared atrial myocardium who were successfully surgically separated is described. Twin B had hypoplastic right heart syndrome and was dependent on Twin A for oxygenation of her blood. The twins were surg